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Abstract
Activation and translocation of protein kinases C is a key event in the regulation of T lymphocyte activation,
proliferation and function. Stimulation of human peripheral blood lymphocytes with the monoclonal antibody BMA 031
raised against the T cell antigen receptor led to a bimodal activation of protein kinases C. The immediate activation and
translocation of the protein kinase C isoform PKC-a was followed by activation and translocation of the protein kinase C-b
isoenzyme after 90 min of stimulation. Pretreatment of the cells with cholera toxin for 90 min completely abolished
activation of protein kinase C-a . In sharp contrast, activation and translocation of protein kinase C-b was not influenced by
the bacterial toxin, suggesting that activation and translocation of different protein kinase C isoenzymes are regulated by
distinct mechanisms of transmembrane signalling coupled to the T cell antigen receptorrCD3 complex.
The expression of high affinity IL-2 receptors was completely inhibited by cholera toxin, while IL-2 synthesis and
secretion were not influenced in BMA 031-stimulated human lymphocytes. Extensive control experiments have shown that
the effects of cholera toxin were not mediated by its B subunit, and were independent of elevation of intracellular cAMP
concentration, suggesting that cholera toxin interfered with a signalling pathway leading to activation of protein kinase C-a ,
which could be responsible for the inhibition of IL-2 receptor expression. This hypothesis was substantiated by the finding
that upon introduction of antibodies against protein kinase C-a , IL-2 receptor gene expression was completely suppressed.
The results suggest, that protein kinase C-a might be the major protein kinase C isoenzyme of a signal transduction cascade
regulating IL-2 receptor expression in stimulated human lymphocytes. q 1997 Elsevier Science B.V. All rights reserved.
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1. Introduction
 .The central role of protein kinase s C in the
course of T lymphocyte activation is well-docu-
mented. Meanwhile, 10 different isotypes of the pro-
tein kinase C family have been shown in T cells. The
mechanisms of their activation are well characterized
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w xin vitro 1–5 . Despite several efforts, the molecular
mechanisms activating differential protein kinase C
isotypes in vivo are not definitely established. Even
more important, the molecular targets and thus the
distinct function of the individual protein kinase C
isoenzymes remains to be elucidated.
In T lymphocytes the binding of antigens or
.monoclonal antibodies to the T cell antigen receptor
results in tyrosine phosphorylation and thus in the
activation of PLC-g , which then hydrolyses mem-
brane associated PIP to the second messengers IP2 3
and diacylglycerol. Once generated, these second
messengers initiate a complex of intracellular events,
including elevation of intracellular calcium and acti-
 .vation of protein kinase s C which ultimately result
w xin cytokine synthesis and proliferation 6,7 . As shown
 .recently, short term activation of protein kinase s C
was sufficient to induce expression of high affinity
IL-2 receptors, sustained activation and translocation
 .of protein kinase s C was, however, necessary for
w xIL-2 gene expression and secretion 8–11 . Our re-
cent work indicated that upon stimulation via T cell
antigen receptor sequential activation of differential
‘classical’ protein kinase C isoenzymes occurs. Upon
stimulation with a monoclonal antibody raised against
the T cell antigen receptor immediate and short term
activation of PKC-a was observed, followed by sus-
tained activation of PKC-b in the later phase of
w xlymphocyte stimulation 12,13 . These results impli-
cated that differential signal transduction pathways
were involved in the activation of PKC-a and -b ,
respectively.
As demonstrated recently, cholera toxin interfered
with T cell receptor-induced transmembrane sig-
nalling at an early step, thus resulting in suppression
of T cell receptor induced activation of phos-
phatidylinositol turnover and finally in inhibition of
cellular proliferation induced by polyclonal mitogens
w xor by specific antigens or antibodies 14,15 . It has
also been shown that inhibition by cholera holotoxin
of lymphocyte activation cannot be explained by the
activation of adenylate cyclase and thus by elevation
w xof intracellular cAMP levels 14 .
In this study the effects of cholera toxin on stimu-
lation of human T-lymphocytes were investigated in
 .detail. The major questions concerned: 1 whether
activation and translocation of the ‘classical’ protein
kinases C were influenced upon interruption of trans-
 .membrane signalling by cholera toxin and 2 whether
IL-2 synthesis and expression of high affinity IL-2
receptors were influenced by impaired activation and
functioning of different protein kinase C isotypes in
human lymphocytes.
Here we show that inhibition by cholera holotoxin
 .but not its B subunit of T cell antigen receptor-in-
duced early signalling prevented early and transient
activation of PKC-a without influencing subsequent
and sustained activation of PKC-b. The data thus
indicate that in human lymphocytes differential
molecular mechanisms are involved in the activation
of PKC-a and -b, respectively. While IL-2 receptor
expression was significantly inhibited by cholera
toxin, IL-2 synthesis was not influenced. Introduction
of antibodies against PKC-a into human lympho-
cytes completely inhibited IL-2 receptor gene expres-
sion without affecting IL-2 synthesis. Thus, our data
indicate that PKC-a might be the major protein
kinase C isoform involved in the regulation of a
signal transduction cascade resulting in IL-2 receptor
expression in stimulated human lymphocytes.
2. Materials and methods
2.1. Materials
 .Mouse monoclonal antibody BMA 031 IgG ,2b
raised against monomorphic determinants of the T
cell antigen receptor, was a kind gift of Dr. Kurrle,
Behringwerke AG, Marburg. Antibodies against
PKC-a , raised against the epitope corresponding to
amino acids 651–672 mapping at the carboxy termi-
nus of PKC-a , were from Santa Cruz Biotechnology.
 .Human recombinant interleukin-2 hr-IL-2 was a
kind gift of Dr. Conradt, GBF, Braunschweig. All
other chemicals were from Sigma
2.2. Cells and cell culture
Peripheral blood lymphocytes were isolated by
FicollrIsopaque gradient centrifugation and depleted
overnight for adherent cells. Cells were washed with
RPMI 1640 and cultured in RPMI 1640, supple-
mented with 10% FCS, 100 U penicillin, 100 mgrml
streptomycin and 2 mM glutamine at a density of
2=106 cellsrml. Lymphocytes were preincubated
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with cholera toxin or its B subunit for 90 min at
concentrations indicated in the experiments, then acti-
vated with the monoclonal antibody, BMA 031 5
. mgrml or by phorbol-12-myristate-13 acetate PMA,
.100 ngrml , respectively, as indicated in the experi-
ments. After incubating cells for 68 h 0.5 mCi of
w3 x  .H thymidinerwell 20 Cirmmol, Amersham was
added for a further 4 h. Cells were then harvested
w3 xwith an automatic cell harvester and H thymidine
incorporation determined by liquid scintillation
counting.
2.3. Determination of IL-2 synthesis
 5Cells 2=10 in 0.2 ml of RPMI mediumr10%
.FCS were preincubated with cholera toxin or its B
subunit, respectively, for 90 min and stimulated with
the monoclonal antibody BMA 031 in flat bottom
microtiter plates for 16 h. The supernatants were
harvested and the concentration of IL-2 quantitated
 .with the help of a commercial ELISA Genzyme .
2.4. Isolation of RNA and PCR
 6 .Human lymphocytes 2=10 rml were preincu-
bated with cholera toxin for 90 min and then stimu-
lated for 12 h with 5 mgrml BMA 031. Total RNA
was isolated on RNAaesy spin columns; cDNA from
2 mg RNA was prepared by reverse transcriptase and
amplified using the PCR Gene Amp RNA PCR kit
w xfrom Perkin-Elmer as described recently 16 . The
primer was synthetized by solid-phase oligonucleo-
 .tide synthesis Pharmacia . The DNA sequence of the
w xIL-2 receptor -a chain was taken from 17,18 . The
sequence of the oligonucleotide was: 5X-GAAAT-
GATAAATTCTCTCTGGGTGGCTTCATT-3X.
2.5. Determination of cAMP concentration
 6Human lymphocytes 2=10 rml in RPMIr10%
.FCS were preincubated with different concentrations
of cholera toxin for 4 h. Cells were then washed and
intracellular cAMP concentrations determined by
w xmeans of a radioimmunoassay as described in 19 .
2.6. Determination of cytosolic calcium concentration
 6Human lymphocytes 2=10 rml in RPMIr10%
.FCS were preincubated with 500 ngrml cholera
toxin for 90 min, then washed and loaded in the dark
with 1 mM Fura-2AM in medium Hanks’ Balanced
 . w xSalt Solution HBSS as described 13 . Cells were
then washed three times and allowed to recover for
30 min at 378C in RPMIr10% FCS. Immediately
before use, aliquots containing 5=106 cells were
washed and resuspended in HBSS, then stimulated
with 5 mgrml BMA 031. Elevation of intracellular
calcium was detected in a fluorescence photometer
with dual excitation at 340 and 380 nm. Emission
was monitored at 505 nm. Cells were lysed with
0.01% Triton-X 100 to determine ratios at maximum
calcium concentrations and then calcium chelated and
removed with 7.5 mM EGTA, pH 8.3, to determine
ratios at minimum calcium concentrations. Fluores-
cence intensity ratios were converted to calcium con-
centrations using a computer program.
2.7. Introduction of anti-PKC antibodies by electro-
poration into human lymphocytes
Electropermeabilization was performed by the ca-
w xpacitor discharge method as described in 12 in a
Bio-Rad Gene Pulser at 208C with slight modifica-
 6 .tions. Briefly, human lymphocytes 2=10 rml in
‘permeabilization buffer’ containing 10 mM Pipes
 .pH 7.4 , 0.5 mM MgCl , 120 mM NaCl, 10 mM2
EGTA and 8.2 mM CaCl were processed to electro-2
poration in the presence of antibodies raised against
PKC-a at concentrations of 1–5 mgrml. As control
 .antibody 2 mgrml rabbit immunoglobulin Dianova
was used. Electropermeabilization was achieved by
using a capacitance of 500 mF at 300 V current,
 .which decreased to 1re st in 8.5 ms. After
electropermeabilization lymphocytes were allowed to
recover in RPMIr50% FCS for 1 h at 378C. Cells
were then washed and viability routinely tested by
trypan blue exclusion test. Alternatively, propidium
iodide incorporation was determined by incubation of
105 cells with 50 ngrml propidium iodide for 20 min
at 48C. Propidium iodide positive cells were analysed
by flow cytometry. Under the conditions used more
than 90% of cells proved to be intact following
w xelectroporation 12 .
2.8. Protein kinase C assay
Protein kinase C was determined in permeabilized
cells with the PKC-specific substrate, peptide GS, as
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w xdescribed 20 . Briefly, cells were washed before
permeabilization with ‘intracellular buffer’ contain-
ing 150 mM KCl, 5 mM MgCl , 12.5 mM PIPES2
 .pH 7.4 , 12.5 mM EGTA and 8.17 mM CaCl . Cells2
were resuspended in ‘intracellular buffer’ in the pres-
ence of peptide GS and phosphorylation with 32P-ATP
 .100 mM, 200 cpmrpmol carried out in a total
volume of 250 ml at 378C 5 min. The reaction was
stopped by the addition of 100 ml portions of 25%
 .wrv trichloroacetic acid in 2 M acetic acid. After
being left on ice for at least 10 min, samples were
centrifuged and aliquots spotted on P81 ion-ex-
change-chromatography paper which was then washed
 .three times in 30% wrv acetic acid containing 1%
H PO . The enzyme activity is expressed as the3 4
difference between the values measured in the pres-
ence and absence of phospholipids and calcium in
nanomoles of 32P transferred per minrmg protein of
the sample.
2.9. Isolation of subcellular fractions from human
lymphocytes
 6 .Lymphocytes 5=10 cellsrml were preincu-
bated with 0.5 mgrml cholera toxin for 90 min, then
 . stimulated with BMA 031 5 mgrml or PMA 100
.ngrml , respectively, for different lengths of time as
indicated in the experiments. Cells were then washed
wand resuspended in isolation buffer 20 mM Hepes
 .xpH:7.4 , 1 mM EGTA, 1 mM EDTA, 5 mM DTE
. 8and 50 mgrml leupeptin at a cell density of 10
cellsrml. Cells were disrupted by nitrogen cavitation,
and cytosolic and plasma membrane fractions iso-
w xlated as described earlier 13 . Protein was deter-
w xmined as described in 21 .
2.10. Determination of protein kinase C acti˝ity in
subcellular fractions
Protein kinase C activity in subcellular fractions
w xwas determined as described elsewhere 12,13 .
Briefly, cytosolic protein kinase C was measured in
aliquots of the cytosolic fraction without further pu-
rification. Plasma membrane bound protein kinase C
was solubilized by 1 mM CHAPS 3-3-chloramido-
.propyl-dimethylammonil-1-propane-sulfonate in iso-
lation buffer for 20 min at 48C setting the protein
concentration to 1 mgrml. The nonsolubilized mate-
rial was removed by centrifugation 100 000=g, 60
.min, 48C . Protein kinase C was measured in a
reaction mixture containing 40 mM HEPES, 10 mM
MgCl , 0.4 mM EGTA, 200 mM peptide GS2
 . 32  .Bachem and 60 mM P-ATP 100 cpmrpmol
with or without 2 mM CaCl , 200 mgrml phos-2
phatidylserine and 20 mgrml 1,2-diolein. Lipids were
dispersed by sonification. The reaction was started by
mixing 100 ml of reaction medium with 10 mg of
sample protein in isolation buffer. After an incubation
of 5 min at 378C reaction was stopped as described
above.
2.11. Detection of protein kinase C isotypes by im-
munoblotting
40 mg membrane protein was processed by SDS-
PAGE on 10% polyacrylamide gels as described in
w x w12 . Electroblotting of proteins to Immobilon mem-
branes was carried out at a constant current of 200
mA for 2 h. Blots were then incubated with mono-
clonal antibodies against protein kinase C-a or pro-
 .tein kinase C-b Seikagaku Kogyo Co, Tokyo , re-
spectively, for 4 h, followed by incubation with a
biotinylated second antibody and streptavidine-
coupled alkaline phosphatase. Nitro-blue-tetrazolium
 .NBT and 5-bromo-4-chloro-3-indolyl-phosphate
 .  .BCIP Amersham were used as substrates to visu-
alize protein kinase C subspecies.
3. Results
3.1. Inhibition by cholera toxin of cellular prolifera-
tion
As shown in Table 1, cholera toxin inhibited BMA
031-induced cellular proliferation of human periph-
eral blood lymphocytes in a concentration dependent
way. Significant inhibition of cellular proliferation
was observed in cells which were preincubated with
at least 0.5 mgrml cholera toxin for 90 min. In order
to establish whether for inhibition of lymphocyte
proliferation the intact toxin was required or, alterna-
tively, the binding of its B subunit to gangliosides
was sufficient, the effects of the B subunit on BMA
031 activated lymphocytes have been investigated.
As shown in Table 1, cholera toxin B subunit up to a
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Table 1
w3 xEffect of cholera toxin, its B-subunit and db-cAMP on IL-2 synthesis and H thymidine incorporation of BMA 031 stimulated human
lymphocytes
3 . w x  .Treatment Stimulus IL-2 secreted pgrml H thymidine incorporated cpm
None None n.d. 1 981"335
None BMA 031 103.3"5.1 20 720"452
 .CTX mgrml
0.125 BMA 031 109.9"5.5 20 777"1038
0.25 BMA 031 107.5"5.0 19 274"863
0.5 BMA 031 90.9"4.5 5 772"88
1 BMA 031 90.4"5.0 4 155"207
 .CTX-B mgrml
0.1 BMA 031 107.0"2.0 19 891"912
1 BMA 031 98.5"8.0 15 747"472
2 BMA 031 87.1"4.5 13 232"608
 .db-cAMP mM
0.06 BMA 031 100.9"5.0 18 271"913
0.125 BMA 031 98.7"4.5 17 919"396
0.25 BMA 031 87.2"1.9 13 139"156
0.5 BMA 031 15.4"0.8 7 323"116
1.0 BMA 031 n.d. 1 979"98
2.0 BMA 031 n.d. 1 520"76
 .  .Human lymphocytes were preincubated with cholera toxin CTX , cholera toxin B subunit CTX-B or db-cAMP for 90 min,
w3 xrespectively. Cells were then stimulated with BMA 031 for 44 h. H thymidine was then added for 4 h, cells harvested and thymidine
incorporation determined as described under Section 2. Results are means"S.D. of triplicates from two independent experiments. n.d.:
not detectable.
concentration of 2 mgrml had only a marginal effect
on BMA 031 induced proliferation.
Preincubation of human lymphocytes with 0.5
mgrml cholera toxin led to a 10 fold elevation of
intracellular cAMP concentration. In resting cells
cAMP concentration proved to be 20 fmolr2=106
cells while in cholera toxin pretreated lymphocytes
225 fmol cAMPr2=106 cells were detected.
As shown in Table 1, db-cAMP inhibited BMA
031-stimulated thymidine incorporation only at rela-
tively high concentrations, ranging from 0.25–2 mM,
leading to intracellular cAMP concentrations at the
range of 250–900 pmolr2=106 cells. At concentra-
tions reached by cholera toxin treatment no inhibition
of cellular proliferation was observed.
3.2. Lack of effect of cholera toxin on IL-2 synthesis
As shown in Table 1, peripheral blood lympho-
cytes activated with BMA 031 secreted about 100
pgrml IL-2. Preincubation of the cells with cholera
toxin at a concentration as high as 0.5 mgrml re-
sulted only in a marginal depression of IL-2 synthe-
sis, but not to an extent which would explain the
degree of inhibition of T cell proliferation. The B
subunit of cholera toxin up to 2 mgrml had only a
marginal influence on IL-2 synthesis as well as on
cellular proliferation of BMA 031 stimulated human
lymphocytes.
Similar to its effect on proliferation, db-cAMP
inhibited T cell antigen receptor-induced IL-2 synthe-
sis only at high concentrations, the effective concen-
 .trations being as high as 0.25–2 mM Table 1 .
3.3. Inhibition by cholera toxin of IL-2 receptor
expression
When human lymphocytes were stimulated with
BMA 031 increased amounts of the mRNA for IL-2
 .receptor a-chain CD25 were detected after 16 h
 .Fig. 1, lane 2 . Preincubation of cells with 0.5
mgrml cholera toxin led to a markedly reduced
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Fig. 1. Inhibition by cholera toxin of the transcription of CD25 in
BMA 031-stimulated human lymphocytes. Human lymphocytes
 .were preincubated with 0.5 mgrml cholera toxin CTX or 2 mM
db-cAMP, respectively, for 90 min. Cells were then stimulated
with BMA 031 for 12 h. RNA was isolated and RT-PCR carried
out as described in Section 2. A representative experiment out of
three identical ones is shown. Upper part: CD25; lower part:
tubulin, 1: control, 2: BMA 031, 3: controlqCTX, 4: BMA
031qCTX, 5: controlqdb-cAMP, 6: BMA 031qdb-cAMP, 7:
BMA 031qPMA.
 .expression of CD25 Fig. 1, lane 4 . In sharp con-
trast, even at a concentration as high as 2 mM,
db-cAMP had no influence on the enhanced expres-
 .sion of CD25 Fig. 1, lane 6 . Cholera toxin B
subunit at a concentration of 2 mgrml did not influ-
ence IL-2 receptor synthesis and expression data not
.shown .
Taken together, the data shown in Fig. 1 and in
Table 1 thus suggest that inhibition by cholera toxin
of IL-2 receptor expression was due to a mechanism
different from the elevation of intracellular cAMP
concentration and thus of activation of protein kinase
A in stimulated human lymphocytes.
3.4. Interference of cholera toxin with the increase in
cytosolic free calcium
Activation of T lymphocytes via the T cell antigen
receptor leads to a rapid increase in ‘PI breakdown’
and thus generation second messengers IP and dia-3
w xcylglycerol 1 . Elevation of intracellular calcium and
 .activation of protein kinase s C have been shown to
be crucial events in regulating IL-2 receptor expres-
Fig. 2. Inhibition by cholera toxin of BMA 031-induced elevation
of intracellular calcium concentration. Human lymphocytes were
preincubated with 0.5 mgrml cholera toxin for 90 min. Cells
were then washed and intracellular calcium concentration deter-
mined as described in Section 2. A: control cells; B: lymphocytes
pretreated with cholera toxin; C: cholera toxin treated cells in
q  .‘Ca2 -free’ medium HBSSr1 mM EGTA .
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w xsion during T cell activation 22 . Therefore, it was
obvious to investigate the effects of cholera toxin at
the early step of transmembrane signalling preceding
protein kinase C activation.
As resting human peripheral blood lymphocytes
incorporate very low amounts of labelled inositol into
inositol lipids, elevation of intracellular calcium con-
centration was measured as a parameter for T cell
antigen receptor-induced PI breakdown. As shown in
Fig. 2A, BMA 031 led to an elevation of the intra-
cellular calcium concentration within 1 min. Preincu-
bation of peripheral blood lymphocytes with cholera
toxin prevented BMA 031 induced rapid elevation of
cytoplasmic calcium concentration. In cholera toxin
treated cells a slow elevation of intracellular calcium
concentration was observed upon stimulation Fig.
.2B . The BMA 031 dependent slow elevation of
intracellular calcium was completely abolished by the
addition of 1 mM EGTA to the extracellular medium,
suggesting that cholera toxin did not influence the
opening of calcium channels of the plasma membrane
and thus calcium influx from the extracellular medium
 .into the cells Fig. 2C . In sharp contrast cholera
Fig. 4. Inhibition by cholera toxin of the activation and transloca-
tion of PKC-a. Human lymphocytes were preincubated with 0.5
mgrml cholera toxin. Cells were then washed and plasma mem-
branes isolated as described in Section 2. 40 mg plasma mem-
brane protein was processed to SDS-PAGE and immunoblotting
as described in Section 2. PKC-a and -b were identified with
specific monoclonal antibodies. One of four independent experi-
ments with similar results is shown.
Fig. 3. Inhibition by cholera toxin of BMA 031-induced activation of protein kinase C. Human lymphocytes were preincubated with 0.5
 .  .mgrml cholera toxin CTX or 2 mgrml of its B-subunit CTX-B for 90 min, respectively. Cells were then stimulated with BMA 031
for the times indicated on the abscissa. Protein kinase C activity was determined as described under Section 2. Results are means of
triplicates from three independent experiments. S.D. never exceeded 8%.
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toxin B subunit had no influence on the concentration
of cytoplasmic free calcium, neither in resting nor in
 .BMA 031 stimulated cells data not shown .
3.5. Inhibition by cholera toxin of the early acti˝ation
of PKC-a
As reported earlier and shown in Fig. 3, stimula-
tion with BMA 031 of human peripheral blood lym-
phocytes led to bimodal activation of protein kinase
w xC activity 11–13 . Pretreatment of cells with cholera
toxin abolished the immediate and transient activa-
tion of the enzyme activity without influencing the
late and sustained activation of protein kinase C. As
shown in Fig. 4, it was the early activation of the
Table 2
Lack of effect of cholera holotoxin and of B subunit on the
activation of protein kinase C in PMA stimulated human lympho-
cytes
Stimulation CTX CTX-B PKC activity
1 . min nmol=mg
1 1.proteiny =miny
0 y y 245"12
0 q y 218"22
0 y q 213"51
5 y y 509"43
5 q y 559"38
5 y q 534"42
10 y y 649"30
10 q y 636"45
10 y q 642"51
30 y y 226"34
30 q y 207"19
30 y q 216"15
90 y y 535"46
90 q y 545"37
90 y q 540"41
120 y y 602"41
120 q y 613"32
120 y q 607"30
240 y y 592"22
240 q y 584"33
240 y q 588"47
Human lymphocytes were preincubated with cholera toxin CTX
.  .0.5 mgrml or its B subunit CTX-B, 2 mgrml for 90 min.
 .Cells were then washed and stimulated with PMA 100 ngrml
for the times indicated. Cells were then disrupted, plasma mem-
branes isolated and protein kinase C activity determined as
described under Section 2. Results are means"S.D. of triplicates
of two independent experiments.
Table 3
Lack of effect of db-cAMP on the activation of protein kinase C
Activator PMA Stimulation db-cAMP PKC activity
 . BMA 031 min nmol=mg
1proteiny =
1.miny
y y 0 y 245"12
y y 0 q 207"19
q y 5 y 502"39
q y 5 q 497"22
y q 5 y 559"25
y q 5 q 543"32
q y 10 y 577"30
q y 10 q 566"45
y q 10 y 534"24
y q 10 q 535"41
q y 90 y 602"46
q y 90 q 613"37
y q 90 y 645"32
y q 90 q 636"24
q y 120 y 678"41
q y 120 q 692"35
y q 120 y 684"38
y q 120 q 619"33
Human lymphocytes were preincubated with 2 mM db-cAMP for
1 h. Cells were then washed and stimulated for the times
indicated with 100 ngrml PMA or 5 mgrml BMA 031, respec-
tively. Protein kinase C activity was determined in isolated
plasma membranes as described under Materials and Methods.
Results are means"S.D. of triplicates.
protein kinase C isotype PKC-a which was inhibited
upon cholera toxin treatment between 2 and 10 min,
whilst the long lasting activation of PKC-b between
90 min and 4 h was not changed. Preincubation of
cells with 2 mgrml cholera toxin B subunit did not
influence BMA 031 induced activation of protein
 .kinase C Fig. 3 .
It should be emphasized that direct, PMA induced
 .activation of protein kinase s C was not influenced
by cholera toxin, suggesting that the molecular target
of cholera toxin was a T cell antigen receptor-depen-
dent signalling event upstream of and specifically
involved in the activation and translocation of PKC-a
 .Table 2 . Furthermore, activation and translocation
of PKC was not influenced by db-cAMP, neither in
 .BMA 031 nor in PMA-stimulated cells Table 3 .
Preincubation with cholera toxin B subunit did not
prevent either BMA 031 or PMA mediated transloca-
 .tion of protein kinase s C in human lymphocytes
 .Fig. 3 and Table 2 .
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3.6. Inhibition by anti PKC-a antibodies of IL-2
receptor expression
The data presented so far suggested that cholera
toxin interfered with T cell receptor induced early
signalling resulting in activation of the PKC-isoen-
zyme PKC-a and finally in upregulation of IL-2
 .receptors CD25 in stimulated human lymphocytes.
In order to establish a direct link between activation
of PKC-a and expression of IL-2 receptors, specific
antibodies raised against PKC-a were introduced
into human lymphocytes.
As shown in Fig. 5, neutralization of PKC-a re-
sulted in a complete inhibition of IL-2 receptor
 .  .CD25 expression Fig. 5, lane 5–7 . It should be
emphasized, that neither electroporation nor introduc-
tion of a control immunoglobulin influenced BMA
Fig. 5. Inhibition by anti-PKC-a antibodies of the transcription
of CD25 in BMA 031 stimulated human lymphocytes. Human
lymphocytes were electropermeabilized in the presence of anti-
PKC-a antibodies as described in Section 2. Cells were then
incubated in RPMIr50% FCS for 1 h. After washing T lympho-
cytes were stimulated with BMA 031 for 12 h, RNA was isolated
and RT-PCR carried out as described in Section 2. A representa-
tive experiment out of three is shown. Upper part: CD25; lower
part: tubulin, 1: control, 2: control-electroporated, 3: BMA 031,
4: BMA 031qcontrol immunoglobulin, 5: BMA 031qanti-PKC-
 . a antibody 1 mgrml , 6: BMA 031qanti-PKC-a antibody 2
.  .mgrml , 7: BMA 031qanti-PKC-a antibody 5 mgrml , 8:
BMA 031-electroporated, 9. BMA 031qPMA.
031-induced increase in the amount mRNA for CD
 .25 Fig. 5, lanes 4 and 8 . Under the experimental
conditions used, BMA 031 stimulated IL-2 synthesis
proved to be 100 pgrml, independent of treatment
with either anti-PKC-a antibodies, control immuno-
globulin or electroporation, respectively data not
.shown .
4. Discussion
Binding of monoclonal antibodies to the T cell
antigen receptor transduces signals into the cell re-
sulting in the activation of a variety of genes, among
others that of the cytokine IL-2 and of its high-affin-
ity receptor, which then turn on T cell proliferation
w x1,6,23 . The results presented in this work suggest
that differential signal transduction pathways are in-
volved in the activation of the IL-2 receptor and the
IL-2 gene, respectively.
At least two differential signalling pathways have
to be generated by the T cell antigen receptor. The
first one, involving activation of PLC-g catalysed
PIP breakdown, rapid elevation of intracellular cal-2
cium and diglyceride concentrations led to a rapid
and transient activation of PKC-a , which was sensi-
tive towards cholera toxin. In contrast, another cholera
toxin resistant signalling pathway resulted in late and
sustained activation of PKC-b. Whilst the expression
of high affinity IL-2 receptors was inhibited by
cholera toxin, IL-2 synthesis and secretion were resis-
tant against the drug. Taken together, these data
indicate that differential protein kinase C isotypes
might be involved in the regulation of signal trans-
duction resulting in IL-2 receptor and IL-2 gene
expression in stimulated human T lymphocytes.
T cell receptorrCD3 dependent activation of PLC-
g catalysed PIP breakdown generating IP and thus2 3
.calcium release as well as elevation of the concentra-
tion of diacylglycerol second messengers activated
and translocated rapidly and transiently the protein
kinase C isoenzyme, PKC-a to the plasma membrane
 .Figs. 3 and 4 . Upon cholera toxin treatment early
activation of PKC-a was completely abolished in
BMA 031-stimulated human T lymphocytes. In con-
trast, neither the late and sustained activation of
PKC-b was influenced upon cholera toxin treatment
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of the cells, nor was the PMA-induced direct activa-
tion of any protein kinase C isoform inhibited Fig. 4
.and Table 2 . Thus, the data implicated that the
molecular target of cholera toxin might be localized
between T cell antigen receptor and activation of
PKC-a.
Recent data have shown that the T cell antigen
receptorrCD3 complex was down-regulated by
cholera toxin in Jurkat T cells, thus rendering these
cells resistent to antigen or monoclonal antibody
w xstimulation 15,24 . However, downregulation of the
T cell antigen receptor appeared to be the conse-
quence not the cause of blocking signal transduction
w x15 . On the surface of peripheral blood lymphocytes
no change in the number of T cell antigen receptors
was detectable as revealed by means of different
fluorescein-labelled antibodies raised against the T
 .cell antigen receptorrCD3 complex data not shown .
PLC-g catalysed PI breakdown, as measured by
the rapid increase in intracellular calcium concentra-
tion, was inhibited by cholera toxin in stimulated
 .human T lymphocytes Fig. 2 . It should be men-
tioned, that cholera toxin did not completely block
the T cell antigen receptor-induced enhanced calcium
influx into peripheral blood lymphocytes, suggesting,
that the opening of calcium channels in the plasma
membrane might underlie a mechanism independent
of inositol lipid metabolism and thus suggesting that
an IP independent mechanism might also be effec-3
tive in the regulation of calcium influx in stimulated
human lymphocytes. Recent studies indicated that
sustained elevated calcium concentration was essen-
tial for both the initiation and maintaince of IL-2
gene transcription. Thus it appears that prolonged
elevation of intracellular calcium, rather than the
initial transient increase in calcium, is the critical
component of calcium signalling and that prolonged
elevation of intracellular calcium may be causally
w xlinked to IL-2 gene expression 25 .
As shown recently, cholera toxin led to a covalent
modification of the z-chain of the T cell antigen
receptorrCD3 complex and subsequent inhibition of
w xstimulated ‘PI response’ in Jurkat T cells 15,26 .
Despite the fact that the exact mechanism of this
phenomenon remains to be elucidated, the data clearly
show that modification of the signal transducing ele-
ment, e.g. the z-chain of the CD3 complex inter-
rupted early T cell antigen receptor-induced trans-
w xmembrane signalling 14,15 . The lack of calcium
and diacylglycerol second messengers may thus re-
sult in impaired activation of PKC-a in T cells.
Cholera toxin B subunit proved to be ineffective in
inhibition of T cell receptor induced elevation of
 .intracellular calcium concentration data not shown .
It should be emphasized that even the effects ob-
served in murine T lymphocytes by the cholera toxin
B subunit have been shown not to be involved in
modulation of the phosphatidylinositol messenger
w xsystem 27,28 .
Control experiments have shown that cholera toxin
mediated inhibition of PLC-g was not due to ele-
vated levels of cAMP, as PLC-catalysed ‘PI re-
sponse’ was not influenced by direct activation of the
w xadenylate cyclase in Jurkat T cells 14 . Furthermore,
inhibition by cholera toxin of cellular responses is
hardly to be explained as a consequence of elevated
cAMP levels, resulting from cholera toxin treatment
of the cells by ADP-ribosylation of stimulatory G-
proteins. Neither was the BMA 031-induced activa-
tion of PKC influenced by db-cAMP at a concentra-
 .tion as high as 2 mM Table 3 , nor was the BMA
031-induced elevation of IL-2 receptor mRNA af-
 .fected Fig. 1 . Although cholera toxin at the concen-
tration used resulted in an approximately tenfold
elevation of intracellular cAMP concentration up to
6 .200 fmolr2=10 cells , IL-2 synthesis and cellular
proliferation were resistant to db-cAMP up to a con-
centration of 0.25 mM. Taking in account that ap-
proximately 10% of db-cAMP entered the cells, intra-
cellular cAMP concentration was as high as 250–900
pmolr2=106 cells, e.g. at least three orders of
magnitude higher than that caused by cholera toxin
treatment.
The z-subunit of the T cell antigen receptor has
recently been shown to bind GTP. Functional studies
suggested that GTP binding to the z-chain may be
involved in coupling the T cell antigen receptor to
w xintracellular signalling 29,30 . Inhibition by cholera
toxin of GTP binding to the z-chain of T cell antigen
receptor uncoupled the receptor from further sig-
nalling steps. Thus covalent modification by cholera
toxin of the GTP binding site of the z-chain by a so
far unknown mechanism could result in inhibition of
PLC-g and thus in interruption of subsequent sig-
w xnalling events of T-cell activation 15,26 .
The B subunit of cholera toxin has been reported
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to inhibit activation and proliferation of murine lym-
phocytes induced by polyclonal mitogens or specific
w xantibodies 27 . On the other hand, in certain Jurkat T
cell clones highly expressing GMI cell surface gan-
gliosides elevation of IL-2 synthesis and of tyrosine
.phosphorylation have been observed upon treatment
w xwith cholera toxin B subunit 28 . Our data suggest
that in peripheral T lymphocytes interruption by
cholera toxin of T cell antigen receptor induced
signalling and of IL-2 receptor expression were inde-
pendent of the B subunit.
As shown in Table 1 and Fig. 1, cholera toxin
specifically inhibited upregulation of IL-2 receptor
 .a-chain CD25 in BMA 031-stimulated human lym-
phocytes without influencing IL-2 synthesis and se-
cretion. The fact that cholera toxin specifically inhib-
ited activation of PKC-a suggested that a PKC-a
dependent signalling pathway might regulate IL-2
receptor expression. The finding that neutralization
by specific antibodies of PKC-a completely and
specifically inhibited T cell receptor-induced eleva-
tion in mRNA for IL-2 receptors bears direct evi-
dence of the decisive role of PKC-a in the regulation
of IL-2 receptor expression in human lymphocytes
 .Fig. 5 .
The present results complement our recent obser-
vations, showing that neutralization of PKC-b by the
means of specific antibodies resulted in a significant
inhibition of IL-2 synthesis in stimulated human lym-
phocytes, whereas introduction of antibodies against
PKC-a had no influence on synthesis and secretion
w xof this cytokine in human T lymphocytes 13 . The
data presented in this paper strenghten the notion that
PKC-a was the main isoenzyme involved in the
regulation of IL-2 receptor gene expression in stimu-
lated human lymphocytes.
In this context, it is worth noting that inhibition of
IL-2 synthesis, but not of IL-2 receptor expression,
has been reported to occur upon treatment of T cells
w xwith cyclosporin A 31 . The immunosuppressive
agent has recently been shown to abolish BMA 031-
induced activation of PKC-b, but not that of PKC-a ,
supporting the hypothesis on the regulation of differ-
ential gene expression by different protein kinase C
w xisotypes 12 .
More direct evidence comparing the effects of
protein kinase C mutants in Jurkat T cells support the
hypothesis that activation of PKC-a , p21ras and of
PKC-e represent differential nonlinear signal trans-
duction pathways regulating different parameters of T
w xcell activation, including IL-2 gene expression 32 .
In summary, dissection by cholera toxin of T cell
antigen receptor induced signal transduction path-
ways supports the assumption on differential T cell
receptor dependent mechanisms of activation and on
distinct function of individual ’classical’ protein ki-
nase C isoforms in stimulated human lymphocytes.
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